- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05811741
Impact of Mandibular Canal Trajectory on Paresthesia After Inferior Alveolar Nerve Lateralization
July 7, 2023 updated by: Ferit Bayram, Marmara University
Evaluating the Influence of Mandibular Canal Trajectory on the Duration of Postoperative Paresthesia in Patients Undergoing Inferior Alveolar Nerve Lateralization: A Prospective Cohort Study
This prospective cohort study aims to investigate the relationship between mandibular canal trajectory and the duration of postoperative paresthesia in patients undergoing inferior alveolar nerve lateralization.
The study will assess mandibular canal trajectory using anatomic factors and evaluate nerve sensory function using subjective and objective tests.
Implant success criteria will also be assessed.
The study will be conducted on patients who underwent IANL due to mandibular atrophy and were unable to receive standard or short implant placement.
Data will be collected at regular follow-up visits up to 1-year post-surgery.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
20
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Istanbul, Turkey, 34854
- Marmara University School of Dentistry
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
The study population consisted of consecutive patients who were treated with inferior alveolar nerve lateralization (IANL) at Marmara University Faculty of Dentistry between June 2016 and December 2022.
The patients had missing teeth in the posterior region of the mandible, in whom standard or short implant placement was not possible due to mandibular atrophy.
Description
Inclusion Criteria:
- Patients with atrophied posterior mandible with less than or equal to 6 mm of bone over the inferior alveolar canal
- No previous grafting or implant surgery at the site where nerve lateralization is planned
- No neurosensory impairment
- No contra-indications for implant surgery
Exclusion Criteria:
- Patients who have undergone radiotherapy in the associated area
- Patients using bone-modifying agents
- Smokers with daily consumption of more than ten cigarettes
- Patients with neurosensory impairment due to trauma, tumor, or cancer
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Light touch test results
Time Frame: Visits at 10 days, 1 month, 2 months, 3 months, 6 months, and 1 year after surgery
|
The light touch test is a common diagnostic tool used to assess sensory perception.
Patients' lower lip and chin areas will be gently stroked with a soft object, such as a piece of cotton or a brush.
The patients will then be asked to report their sensation.
If they feel the touch, the response is considered normal.
However, any reported changes, such as numbness or tingling, can indicate possible nerve damage or recovery after surgery.
|
Visits at 10 days, 1 month, 2 months, 3 months, 6 months, and 1 year after surgery
|
2-point discrimination test results
Time Frame: isits at 10 days, 1 month, 2 months, 3 months, 6 months, and 1 year after surgery.
|
The 2-point discrimination test is a neurological examination used to measure tactile spatial acuity.
Two points of a caliper will be applied to the patients' lower lip and chin areas.
The distance at which a patient can no longer differentiate between the two points provides an indicator of sensory nerve function.
Any reported changes in the ability to distinguish between two points may suggest alterations in nerve sensitivity or recovery after surgery.
|
isits at 10 days, 1 month, 2 months, 3 months, 6 months, and 1 year after surgery.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Implant stability quotient (ISQ) values:
Time Frame: During implant placement and follow-up visits at 3 months.
|
The Implant Stability Quotient (ISQ) is a metric ranging from 1 to 100 that is used to assess implant stability within the bone, with higher values indicating greater stability.
To determine ISQ values, resonance frequency analysis (RFA) or sound waves are passed through a specialized peg attached to the implant.
|
During implant placement and follow-up visits at 3 months.
|
Change in peri-implant bone resorption
Time Frame: At 3 months, and 12 months after surgery.
|
This outcome measure evaluates peri-implant bone resorption using OPTG.
The amount of bone loss around the implant will be assessed and recorded.
|
At 3 months, and 12 months after surgery.
|
Patient satisfaction
Time Frame: At 12 month follow-up visit
|
This outcome measure assesses patient satisfaction using a visual analog scale.
Patients will be asked to rate their satisfaction with the treatment outcome at the 12-month follow-up visit.
|
At 12 month follow-up visit
|
Thickness of the buccal cortex
Time Frame: At baseline
|
This outcome measure evaluates the thickness of the buccal cortex using radiographic measurements obtained from CBCT scans.
|
At baseline
|
Thickness of the mandibular inferior border
Time Frame: At baseline
|
This outcome measure evaluates the thickness of the mandibular inferior border using radiographic measurements obtained from CBCT scans.
|
At baseline
|
Diameter of the nerve canal
Time Frame: At baseline
|
This outcome measure evaluates the diameter of the nerve canal using radiographic measurements obtained from CBCT scans.
|
At baseline
|
Distance from the nerve canal to the buccal cortex
Time Frame: At baseline
|
This outcome measure evaluates the distance from the nerve canal to the buccal cortex using radiographic measurements obtained from CBCT scans.
|
At baseline
|
Distance from the nerve canal to the inferior border of the mandible
Time Frame: At baseline
|
This outcome measure evaluates the distance from the nerve canal to the inferior border of the mandible using radiographic measurements obtained from CBCT scans.
|
At baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Alling CC. Lateral repositioning of inferior alveolar neurovascular bundle. J Oral Surg. 1977 May;35(5):419. No abstract available.
- Palacio Garcia-Ochoa A, Perez-Gonzalez F, Negrillo Moreno A, Sanchez-Labrador L, Cortes-Breton Brinkmann J, Martinez-Gonzalez JM, Lopez-Quiles Martinez J. Complications associated with inferior alveolar nerve reposition technique for simultaneous implant-based rehabilitation of atrophic mandibles. A systematic literature review. J Stomatol Oral Maxillofac Surg. 2020 Sep;121(4):390-396. doi: 10.1016/j.jormas.2019.12.010. Epub 2020 Jan 2.
- Kan JY, Lozada JL, Goodacre CJ, Davis WH, Hanisch O. Endosseous implant placement in conjunction with inferior alveolar nerve transposition: an evaluation of neurosensory disturbance. Int J Oral Maxillofac Implants. 1997 Jul-Aug;12(4):463-71.
- Abayev B, Juodzbalys G. Inferior Alveolar Nerve Lateralization and Transposition for Dental Implant Placement. Part II: a Systematic Review of Neurosensory Complications. J Oral Maxillofac Res. 2015 Mar 30;6(1):e3. doi: 10.5037/jomr.2014.6103. eCollection 2015 Jan-Mar.
- Jung RE, Al-Nawas B, Araujo M, Avila-Ortiz G, Barter S, Brodala N, Chappuis V, Chen B, De Souza A, Almeida RF, Fickl S, Finelle G, Ganeles J, Gholami H, Hammerle C, Jensen S, Jokstad A, Katsuyama H, Kleinheinz J, Kunavisarut C, Mardas N, Monje A, Papaspyridakos P, Payer M, Schiegnitz E, Smeets R, Stefanini M, Ten Bruggenkate C, Vazouras K, Weber HP, Weingart D, Windisch P. Group 1 ITI Consensus Report: The influence of implant length and design and medications on clinical and patient-reported outcomes. Clin Oral Implants Res. 2018 Oct;29 Suppl 16:69-77. doi: 10.1111/clr.13342.
- Jensen O, Nock D. Inferior alveolar nerve repositioning in conjunction with placement of osseointegrated implants: a case report. Oral Surg Oral Med Oral Pathol. 1987 Mar;63(3):263-8. doi: 10.1016/0030-4220(87)90187-3.
- Lorean A, Kablan F, Mazor Z, Mijiritsky E, Russe P, Barbu H, Levin L. Inferior alveolar nerve transposition and reposition for dental implant placement in edentulous or partially edentulous mandibles: a multicenter retrospective study. Int J Oral Maxillofac Surg. 2013 May;42(5):656-9. doi: 10.1016/j.ijom.2013.01.020. Epub 2013 Mar 6.
- Lee JH, Son YJ, Hwang JH, Baek SH, Jeon JH. Influence of anatomic position and intraoperative exposure of the inferior alveolar nerve on neurosensory disturbance after sagittal split ramus osteotomy: a three-dimensional computed tomography study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016 Sep;122(3):300-5. doi: 10.1016/j.oooo.2016.04.008. Epub 2016 Apr 23.
- Rathod M, Kshirsagar RA, Joshi S, Pawar S, Tapadiya V, Gupta S, Mahajan V. Evaluation of Neurosensory Function Following Inferior Alveolar Nerve Lateralization for Implant Placement. J Maxillofac Oral Surg. 2019 Jun;18(2):273-279. doi: 10.1007/s12663-018-1124-1. Epub 2018 Jun 2.
- Zarb GA, Albrektsson T. Consensus report: towards optimized treatment outcomes for dental implants. J Prosthet Dent. 1998 Dec;80(6):641. doi: 10.1016/s0022-3913(98)70048-4. No abstract available.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2016
Primary Completion (Actual)
December 1, 2021
Study Completion (Actual)
April 1, 2022
Study Registration Dates
First Submitted
April 1, 2023
First Submitted That Met QC Criteria
April 1, 2023
First Posted (Actual)
April 13, 2023
Study Record Updates
Last Update Posted (Actual)
July 10, 2023
Last Update Submitted That Met QC Criteria
July 7, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MUDHF_FB_006
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alveolar Bone Loss
-
Alexandria UniversityLehigh UniversityCompletedBone Loss | Horizontal Alveolar Bone Loss | Vertical Alveolar Bone LossEgypt
-
Pontificia Universidade Católica do Rio Grande...KU Leuven; ITI International Team for Implantology, Switzerland; Rio Grande do...Not yet recruitingAlveolar Bone Loss | Bone Loss, Alveolar | Grafting Bone | Alveolar Bone Atrophy | Bone Loss, OsteoclasticBrazil
-
Universidad de MurciaUnknownTooth Loss | Bone Loss, Alveolar | Bone Atrophy, AlveolarSpain
-
Università degli Studi di FerraraAzienda USL FerraraRecruitingBone Loss, Alveolar | Dehiscence | Alveolar Ridge EnlargementItaly
-
Postgraduate Institute of Dental Sciences RohtakNot yet recruitingBone Loss, AlveolarIndia
-
University of MichiganActive, not recruiting
-
Rio de Janeiro State UniversityCompleted
-
Esraa Salem KamalRecruiting
-
Cairo UniversityRecruiting
-
Xeolas Pharmaceuticals LimitedRecruiting